Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
77 Results for "
RDCs
" in MedChemExpress (MCE) Product Catalog:
Products (77)
77 Results for "RDCs" in MCE Product Catalog:
4
4 Cited Publications
Synonyms: Oxodotreotide
Research Areas:
4
4 Cited Publications
Synonyms: Oxodotreotide acetate
Research Areas:
2
2 Cited Publications
Synonyms: DOTATOC; SDZ-SMT 487; SMT 487
Research Areas:
2
2 Cited Publications
Cat. No.: HY-P5126
CAS No.: 1192362-32-5
Research Areas:
2
2 Cited Publications
Research Areas:
2
2 Cited Publications
Cat. No.: HY-P5126A
Research Areas:
1
Research Areas:
Cat. No.: HY-W087187
CAS No.: 1375475-53-8
DOTAGA-anhydride is a DOTA-based metal chelator that can bind to radionuclides and is used to prepare radionuclide drug conjugates (RDCs). DOTAGA-anhydride has been successfully used for labeling antibodies (e.g., Trastuzumab (HY-P9907)). DOTAGA-anhydride can be used for the synthesis of a bimodal tag for Single-photon emission computed tomography (SPECT) or PET/optical imaging .
Cat. No.: HY-P10761
CAS No.: 2941391-49-5
Research Areas:
Cat. No.: HY-W1124925
CAS No.: 3066439-94-6
Research Areas:
Cat. No.: HY-164569
CAS No.: 1639843-65-4
Research Areas:
NH2 DOTA-GA is a DOTA-based metal chelator that can be used to prepare radionuclide drug conjugates (RDCs) whose carboxylic acid groups can complex metal ions, for example, NH2 DOTA-GA complexes Gd(III) ions.
Cat. No.: HY-P2218
CAS No.: 1821136-83-7
Research Areas:
Cat. No.: HY-P2112
CAS No.: 619300-53-7
Synonyms: DOTA-Nal3-octreotide
Research Areas:
Cat. No.: HY-P5018
CAS No.: 1820563-84-5
Research Areas:
Cat. No.: HY-164731
Research Areas:
Mal-PEG12-DOTA is a RDC linker that can be used for the synthesis of RDC.
Cat. No.: HY-P10292
Research Areas:
Cat. No.: HY-P10729A
Research Areas:
Cat. No.: HY-164574
CAS No.: 2565792-45-0
Research Areas:
BCN-DOTA is a cyclooctyne-linked DOTA chelator. BCN-DOTA integrates BCN and DOTA, enabling conjugation with azide-functionalized groups via the click chemistry properties of BCN, while binding to metal ions through the coordination capacity of DOTA. BCN-DOTA can serve as a radionuclide-drug conjugate (RDC) to target specific biomolecules, cells or tissues after radiolabeling with zirconium-89. BCN-DOTA is applicable to research related to PET imaging and targeted therapy .
Cat. No.: HY-P5290
CAS No.: 2213408-17-2
Research Areas:
Cat. No.: HY-159770A
CAS No.: 2740747-99-1
Research Areas:
(S)-EB-FAPI-B2 (Compound II-11) is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
